Modulation of mdrl expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance
1996

Cytokines and Multidrug Resistance in Colon Cancer

publication Evidence: moderate

Author Information

Author(s): U Stein, W Walther, RH Shoemaker

Primary Institution: National Cancer Institute

Hypothesis

Can cytokines modulate multidrug resistance in colon carcinoma cells?

Conclusion

Cytokines can effectively reverse multidrug resistance in colon carcinoma cells, enhancing their sensitivity to chemotherapy.

Supporting Evidence

  • Cytokines TNFa, IL-2, and IFNy were shown to decrease mdrl expression in colon carcinoma cells.
  • Cytokine treatment enhanced the accumulation of doxorubicin in resistant cancer cells.
  • The maximum effect of cytokine treatment on mdrl expression was observed after 48 hours.

Takeaway

Cytokines can help cancer cells respond better to treatment by making them less resistant to drugs.

Methodology

The study used RT-PCR and flow cytometry to analyze the effects of cytokines on mdrl expression and P-glycoprotein function in colon carcinoma cell lines.

Limitations

The study primarily focused on in vitro models, and results may not directly translate to in vivo conditions.

Statistical Information

P-Value

p<0.0004

Statistical Significance

p<0.0004

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication